The Peptide Sourcing Field Guide

The biggest names in this market keep disappearing. When they do, the hard question is the same every time: who's actually legit, and how would you even know? This is how to read a vendor before you trust one. It is education, not a recommendation to buy anything.

1. A COA is the floor, not the ceiling

A Certificate of Analysis is a lab report on identity and purity. It is the single most cited trust signal, and the easiest to fake. A real COA names the testing lab, a batch or lot number, the test date, the method (HPLC and mass spec are common), and a result you can tie to the exact product in front of you. A PDF with no lab name, no lot number, or a date that never changes across products is not evidence. It is decoration.

• Match the lot. The lot on the COA should match the lot on the vial. No match, no proof.
• Call the lab. Independent labs will confirm a report number. Made-up ones cannot.
• Third-party only. A COA from the seller's own "lab" tells you very little.

2. Read the vendor, not the marketing

Roughly 42% of online peptide products have tested with content that does not match the label. That number is why provenance matters more than a slick site. Signals that a seller is operating seriously rather than flipping boxes from a warehouse:

• A consistent batch-testing history, not a single COA reused forever.
• Clear, boring logistics: cold-chain handling, real return policy, a physical address.
• Language that stays educational. Sellers promising it will treat, cure, or guarantee anything are telling you they do not respect the rules, which usually means they do not respect much else.

3. Red flags that should stop you cold

• "DM for a source." Real operations do not run sourcing through direct messages.
• Reused or undated COAs. See section 1.
• Cure and treatment claims. These are illegal for this category and a tell that the seller cuts corners.
• Prices far below everyone else. Underpriced product is underpriced for a reason.
• No way to verify anything. If nothing checks out independently, treat all of it as unverified.

4. What the 2026 FDA moves actually changed

Two things matter for sourcing right now. First, the FDA ended compounding discretion for the major GLP-1 drugs and proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list entirely. Second, the agency made clear that a "research use only" or "not for human consumption" label is not a shield. Intent is read from context. That is why the legal ground under a lot of familiar sellers shifted in 2025 and 2026, and why several of the biggest ones are simply gone.

5. The five questions to ask before you trust a source

• Can I tie a third-party COA to this exact lot?
• Who is the testing lab, and will they confirm the report?
• What is the batch-testing history, not just one report?
• Does the seller make any treatment or cure claim anywhere?
• If something is wrong, is there a real person and policy behind it?

This guide is independent education and news, not medical advice. Nothing here is a recommendation to buy, use, or dose any compound. Talk to a qualified clinician about your health.